Targeting TB prevention for individuals and communities
Optimal targeting for individual and population-level TB prevention
This study is all about finding out who is most at risk for tuberculosis in different communities so that we can better target prevention efforts and help those people get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10737631 on NIH RePORTER |
What this research studies
This research focuses on improving tuberculosis (TB) prevention by identifying individuals and groups at the highest risk within communities. It uses advanced statistical methods to analyze data on TB cases and population characteristics, allowing for tailored risk predictions. By understanding who is most at risk, the research aims to optimize the delivery of preventive services and provide patients with clear information about their TB risks. This approach seeks to enhance screening and treatment initiation among those who need it most.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in communities with varying levels of TB exposure and those who have been tested for latent TB infection.
Not a fit: Patients who are not at risk for TB or who have already received effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective TB prevention strategies, reducing the incidence of the disease in high-risk populations.
How similar studies have performed: Previous research has shown success in using data-driven approaches to target public health interventions, indicating that this methodology has potential for effective outcomes.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Menzies, Nicolas a — Harvard School of Public Health
- Study coordinator: Menzies, Nicolas a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.